2019.04.10
FY02/2019 Q4 Results Earnings Release Presentation
2019.03.01PDF(108KB)
Notification of a Subsidiary's Share Transfer
2019.02.05PDF( 48KB)
Hisamitsu Pharmaceutical and Kyowa Hakko Kirin sign Commercialization Agreement for HP-3000, a Potential New Transdermal Patch for Parkinson's Disease in Japan
2019.01.11
FY02/2019 Q3 Results Earnings Release Presentation
2018.12.17PDF(108KB)
Notification of a New Drug Application for HP-3070 (Transdermal Patch for the Treatment of Schizophrenia) in the U.S.